Bryan E. Linggi
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Oncology top 5%
- HER2/EGFR in Cancer Research
Papers in
-
- Acute Myeloid Leukemia Research 8
- Oncology 9
- HER2/EGFR in Cancer Research 4
- Co-authors
- Guy H. Carpenter (1 shared paper)Scott W. Hiebert (8 shared papers)Bart A. Lutterbach (4 shared papers)Edward Seto (2 shared papers)Jennifer J. Westendorf (2 shared papers)Jennifer J. Westendorf (1 shared paper)H. Steven Wiley (5 shared papers)Mariko Moniwa (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)Nature Medicine (2 papers)Journal of Crohn s and Colitis (2 papers)iScience (1 paper)Integrative Biology (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Bryan E. Linggi
30 papers receiving 2.7k citations
Bryan E. Linggi's Hit Papers
Peers
Comparison fields: 5 of 135
- Hematology 560
- Oncology 633
- Molecular Biology 1.6k
- Immunology 357
- Genetics 433
Countries citing papers authored by Bryan E. Linggi
This map shows the geographic impact of Bryan E. Linggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan E. Linggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan E. Linggi more than expected).
Fields of papers citing papers by Bryan E. Linggi
This network shows the impact of papers produced by Bryan E. Linggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan E. Linggi. The network helps show where Bryan E. Linggi may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan E. Linggi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease Hit paper breakdown → | 2017 | 633 |
| 2 | 1998 | 372 | |
| 3 | 2009 | 310 | |
| 4 | 2006 | 305 | |
| 5 | 2000 | 219 | |
| 6 | 2002 | 218 | |
| 7 | 2011 | 112 | |
| 8 | 2000 | 92 | |
| 9 | 2014 | 74 | |
| 10 | 2006 | 54 | |
| 11 | 2005 | 49 | |
| 12 | 2013 | 47 | |
| 13 | 2005 | 46 | |
| 14 | 2013 | 43 | |
| 15 | 2013 | 30 | |
| 16 | 2014 | 27 | |
| 17 | 2001 | 24 | |
| 18 | 2021 | 24 | |
| 19 | 2003 | 20 | |
| 20 | 2003 | 17 |
About Bryan E. Linggi
Bryan E. Linggi is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 2.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Inflammatory Bowel Disease (6 papers), HER2/EGFR in Cancer Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Protein Degradation and Inhibitors (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Genomics and Chromatin Dynamics (3 papers) and Genomics and Phylogenetic Studies (2 papers). The work is most often cited by research in Hematology (560 citations), Oncology (633 citations), Molecular Biology (1.6k citations), Immunology (357 citations) and Genetics (433 citations). Bryan E. Linggi has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Guy H. Carpenter, Scott W. Hiebert, Bart A. Lutterbach, Edward Seto, Jennifer J. Westendorf, Jennifer J. Westendorf, H. Steven Wiley, Mariko Moniwa, Vivian J. Bardwell and Michael G. Rosenfeld. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine, Journal of Crohn s and Colitis, iScience and Integrative Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.